CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文
MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：58/0  |  提交时间：2021/11/04
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
Molecular Cancer, 2021, 卷号: 20, 期号: 1
作者:  Zhang,Tao;  Qu,Rong;  Chan,Shingpan;  Lai,Mengzhen;  Tong,Linjiang
收藏  |  浏览/下载：41/0  |  提交时间：2021/11/04
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 220, 页码: 18
作者:  Xu, Dandan;  Sun, Deqiao;  Wang, Wei;  Peng, Xia;  Zhan, Zhengsheng
收藏  |  浏览/下载：47/0  |  提交时间：2021/08/17
SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014) 期刊论文
CANCER LETTERS, 2020, 卷号: 486, 页码: 71-72
作者:  Wang, Lu;  Ai, Jing;  Shen, Yanyan;  Zhang, Haotian;  Peng, Xia
收藏  |  浏览/下载：10/0  |  提交时间：2020/12/24
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：40/0  |  提交时间：2020/07/01
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. 期刊论文
CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 70-70
作者:  Dai, Yang;  Ji, Yichun;  Shen, Yanyan;  Su, Yi;  Liu, Bo
收藏  |  浏览/下载：26/0  |  提交时间：2020/07/01
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16
作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun
收藏  |  浏览/下载：7/0  |  提交时间：2020/07/01
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1 期刊论文
Journal of Experimental & Clinical Cancer Research, 2019, 卷号: 38, 期号: 1
作者:  Xia Peng;  Pengcong Hou;  Yi Chen;  Yang Dai;  Yinchun Ji
收藏  |  浏览/下载：1/0  |  提交时间：2021/12/01
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2018, 卷号: 17, 期号: 4, 页码: 751-762
作者:  Ai, Jing;  Chen, Yi;  Peng, Xia;  Ji, Yinchun;  Xi, Yong
收藏  |  浏览/下载：52/0  |  提交时间：2019/01/08
identificationofcompoundd2923asanovelantitumoragenttargetingcsf1r 期刊论文
actapharmacologicasinica, 2018, 卷号: 039, 期号: 011, 页码: 1768
作者:  Liu Yingqiang;  Wang Yanan;  Lu Xiaoyun;  Tong Linjiang;  Li Yan
收藏  |  浏览/下载：2/0  |  提交时间：2020/07/01

©版权所有 ©2017 CSpace - Powered by CSpace